cimadronate has been researched along with 2-(2-pyridyl)ethylidine-1,1-bisphosphonate in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (2-(2-pyridyl)ethylidine-1,1-bisphosphonate) | Trials (2-(2-pyridyl)ethylidine-1,1-bisphosphonate) | Recent Studies (post-2010) (2-(2-pyridyl)ethylidine-1,1-bisphosphonate) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 6 | 0 | 0 |
| Protein | Taxonomy | cimadronate (IC50) | 2-(2-pyridyl)ethylidine-1,1-bisphosphonate (IC50) |
|---|---|---|---|
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.1446 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, BL; Dunford, JE; Ebetino, FH; Kavanagh, KL; Kwaasi, AA; Oppermann, U; Rogers, MJ; Russell, RG | 1 |
1 other study(ies) available for cimadronate and 2-(2-pyridyl)ethylidine-1,1-bisphosphonate
| Article | Year |
|---|---|
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Topics: Binding Sites; Diphosphonates; Enzyme Inhibitors; Geranyltranstransferase; Humans; Models, Molecular; Molecular Structure; Nitrogen; Stereoisomerism; Structure-Activity Relationship; Time Factors | 2008 |